BOSC Risk Assessment Workshop
EPA Chemical Risk Assessment Principles and Practices
The Board of Scientific Counselors (BOSC) hosted a workshop on February 2-3, 2005 in response to a white paper on "Risk Assessment Principles and Practices," recently issued by EPA's Office of the Science Advisor. The white paper documents current risk assessment practices at EPA, and the BOSC will address issues in Chapter 4 of the white paper, "Use of Default and Extrapolation Assumptions." Other professional societies are providing feedback on the white paper in the areas of probabilistic methods in risk assessment, methods of uncertainty analysis, and ecological risk assessment. The BOSC workshop focused on providing constructive feedback for refining EPA's current practices or suggesting alternative approaches for default and extrapolation assumptions. Specifically, the workshop covered three topics:
-
Use of default assumptions and uncertainty factors
Speakers include: Hillary Carpenter, Minnesota Department of Health; Mike Dourson, Toxicology Excellence for Risk Assessment (TERA); and Jennifer Sass, Natural Resources Defense Council (NRDC) -
Extrapolation from high to low doses
Speakers include: Rory Conolly, CIIT Centers for Health Research; Tom Starr, TBS Associates; and Lauren Zeise, California EPA -
Extrapolation between species
Speakers include: Mel Andersen, CIIT Centers for Health Research; Jim Bus, Dow Chemical Corporation; and Susan Sumner, RTI International
Draft Agenda (PDF, 3pp., 22KB, about PDF)
Announcement Flyer (PDF, 1pp., 34KB, about PDF)
Risk Assessment Principles and Practices White Paper
Workshop Proceedings (PDF, 55pp., 534KB, about PDF)
Recommendations and ORD Response
Wednesday, February 2, 2005
| 8:00 | Registration |
| 8:30 |
Welcome and Introductions Workshop on EPA Chemical Risk Assessment Principles and Practices Dr. Rogene Henderson, Lovelace Respiratory Research Institute, BOSC Vice-Chair and Workshop Chair Staff Paper: Evaluation of EPA Risk Assessment Principles and Practices Dr. William Farland, EPA Acting Science Advisor |
| Session 1 - Extrapolation From High to Low Doses | |
| 8:45 |
Introduction to Session 1 Dr. Rogene Henderson, Lovelace Respiratory Research Institute |
| 9:00 |
High-to-Low Dose Extrapolation: Issues and Approaches Dr. Weihsueh Chiu, EPA / ORD / NCEA |
| 9:30 |
Biologically-motivated approaches to extrapolation from high to low doses and the advent of systems biology: The road to toxicological safety assessment Dr. Rory Conolly, CIIT Centers for Health Research |
| 10:00 | Break |
| 10:30 |
Some Issues Regarding High-to-Low Dose Extrapolation Dr. Thomas Starr, TBS Associates |
|
Considerations for Improving High to Low Dose Extrapolation Dr. Lauren Zeise, California EPA |
|
| 11:30 | Discussion |
| 12:30 | Lunch |
| Session 2 - Use of Default Assumptions and Uncertainty Factors | |
| 1:30 |
Introduction to Session 2 Dr. George Daston, BOSC Member and Moderator |
| 1:45 |
Default Assumptions, Uncertainty Factors - EPA's Approach Dr. Rita Schoeny, EPA / OW |
| 2:15 |
A State's Approach to Risk-Based Analysis: Similarities to and Differences from EPA's Principles and Practices Dr. Hillary Carpenter, Minnesota Department of Health |
| 2:45 | Break |
| 3:15 |
Past and Future Use of Default Assumptions and Uncertainty Factors Dr. Michael Dourson, Toxicology Excellence for Risk Assessment |
| 3:45 |
NRDC Comments to BOSC on the Use of Default Assumptions and Uncertainty Factors in EPA Risk Assessments Dr. Jennifer Sass, Natural Resources Defense Council |
| 4:15 | Discussion |
Thursday, February 3, 2005
| Session 3 - Extrapolation Between Species | |
| 8:30 |
Introduction to Session 3 Dr. Clifford Duke, BOSC Member and Moderator |
| 8:45 |
EPA Risk Assessment Practice: Extrapolation Between Species Dr. Kerry Dearfield, EPA / OSA |
| 9:15 |
Mode of Action and Dosimetry Considerations in Interspecies Extrapolation Dr. Mel Andersen, CIIT Centers for Health Research |
| 9:45 | Break |
| 10:00 |
Extrapolation Between Species: Issues and Opportunities for the Future Dr. Jim Bus, Dow Chemical |
| 10:30 |
Biomarkers and Species Comparisons (Metabolism & Metabolomics) Dr. Susan Sumner, RTI International |
| 11:00 | Discussion |
| New Directions for Risk Assessment and Workshop Wrap-Up | |
| 12:00 |
A. Risk Assessment at EPA: The Science Behind the Assessments Dr. Peter Preuss, Director, EPA / ORD / NCEA B. Meeting Wrap-up C. Final Remarks Dr. Rogene Henderson, Lovelace Respiratory Research Institute |
![[logo] US EPA](http://www.epa.gov/epafiles/images/logo_epaseal.gif)